Aquinox Pharmaceuticals to Announce Year End 2014 Financial Results and Host Conference Call on March 16, 2015
10 mars 2015 09h20 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 LEADERSHIP Trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis
02 mars 2015 16h52 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 2, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference
23 févr. 2015 09h10 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Changes to Board of Directors
17 févr. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 FLAGSHIP Trial of AQX-1125 in Chronic Obstructive Pulmonary Disease Exacerbations
02 févr. 2015 09h10 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Present at Upcoming Investor Conferences
29 janv. 2015 09h20 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial of AQX-1125 in Atopic Dermatitis
30 déc. 2014 16h05 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 30, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Appointment of Mr. David C. Mitchell as Vice President, Global Regulatory Affairs & Quality Assurance
09 déc. 2014 09h20 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 9, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Third Quarter 2014 Financial Results
04 nov. 2014 09h20 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 4, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Second Quarter 2014 Financial Results
11 août 2014 16h10 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...